SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Flavio Paterno, Koffi Wima, Richard S. Hoehn, Madison C. Cuffy, Tayyab S. Diwan, Steve E. Woodle, Daniel E. Abbott, Shimul A. Shah, Use of Elderly Allografts in Liver Transplantation, Transplantation, 2016, 100, 1, 153

    CrossRef

  2. 2
    Wassim Rahman, Thomas Tu, Magdalena Budzinska, Pauline Huang, Larissa Belov, Jeremy S. Chrisp, Richard I. Christopherson, Fiona J. Warner, D. Scott Bowden, Alexander J. Thompson, David G. Bowen, Simone I. Strasser, David Koorey, Alexandra F. Sharland, Jean Y. H. Yang, Geoffrey W. McCaughan, Nicholas A. Shackel, Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays, Transplantation, 2015, 99, 9, e120

    CrossRef

  3. 3
    William C. Chapman, Neeta Vachharajani, Kelly M. Collins, Jackie Garonzik-Wang, Yikyung Park, Jason R. Wellen, Yiing Lin, Surendra Shenoy, Jeffrey A. Lowell, M.B. Majella Doyle, Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age, Journal of the American College of Surgeons, 2015, 221, 1, 59

    CrossRef

  4. 4
    Arun Jesudian, Sameer Desale, Jonathan Julia, Elizabeth Landry, Christopher Maxwell, Bhaskar Kallakury, Jacqueline Laurin, Kirti Shetty, Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus, Journal of Clinical and Experimental Hepatology, 2015,

    CrossRef

  5. You have free access to this content5
    Adam Peyton, Kalyan Ram Bhamidimarri, Hepatitis C treatment in liver transplant setting, Clinical Liver Disease, 2015, 5, 6
  6. 6
    Peter G. Stock, Norah A. Terrault, Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle, Hepatology, 2015, 61, 5
  7. 7
    Kristel Mils, Laura Lladó, Juan Fabregat, Carme Baliellas, Emilio Ramos, Lluís Secanella, Juli Busquets, Núria Pelaez, Outcomes of Liver Transplant With Donors Over 70 Years of Age, Cirugía Española (English Edition), 2015, 93, 8, 516

    CrossRef

  8. 8
    Kristel Mils, Laura Lladó, Juan Fabregat, Carme Baliellas, Emilio Ramos, Lluís Secanella, Juli Busquets, Núria Pelaez, Resultados del trasplante hepático con donantes de más de 70 años, Cirugía Española, 2015, 93, 8, 516

    CrossRef

  9. 9
    Masahiko Taniguchi, Tsuyoshi Shimamura, Satoru Todo, Hiroyuki Furukawa, Small-for-size syndrome in living-donor liver transplantation using a left lobe graft, Surgery Today, 2015, 45, 6, 663

    CrossRef

  10. 10
    Melisa Dirchwolf, Jennifer L. Dodge, Jane Gralla, Kiran M. Bambha, Trevor Nydam, Kenneth W. Hung, Hugo R. Rosen, Sandy Feng, Norah A. Terrault, Scott W. Biggins, The corrected donor age for hepatitis C virus–infected liver transplant recipients, Liver Transplantation, 2015, 21, 8
  11. 11
    Tayyab S. Diwan, Flavio Paterno, Shimul A. Shah, Use of Extended Criteria Deceased Donors in Adult Liver Transplantation, Current Surgery Reports, 2015, 3, 9

    CrossRef

  12. 12
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  13. You have free access to this content13
    O. Detry, A. Deroover, N. Meurisse, M. F. Hans, J. Delwaide, S. Lauwick, A. Kaba, J. Joris, M. Meurisse, P. Honoré, Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme, British Journal of Surgery, 2014, 101, 7
  14. 14
    Marcio F. Chedid, Charles B. Rosen, Scott L. Nyberg, Julie K. Heimbach, Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors, HPB, 2014, 16, 9
  15. 15
    Sandy Feng, Jennifer C. Lai, Expanded Criteria Donors, Clinics in Liver Disease, 2014, 18, 3, 633

    CrossRef

  16. 16
    Cheng-Maw Ho, Chih-Hsin Lee, Jann-Yuan Wang, Po-Huang Lee, Hong-Shiee Lai, Rey-Heng Hu, Nationwide Longitudinal Analysis of Acute Liver Failure in Taiwan, Medicine, 2014, 93, 4, e35

    CrossRef

  17. 17
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo, Susumu Eguchi, Toshiyoshi Fujiwara, Hideki Ohdan, Hiroaki Nagano, Akinobu Taketomi, Yuko Kitagawa, Mitsuo Shimada, Yonson Ku, Katsuhiko Yanaga, Ken Shirabe, Toru Ikegami, Masashi Mizokami, Masahiro Takeuchi, Yoshihiko Maehara, Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey, Transplant International, 2014, 27, 8
  18. 18
    Shunji Nagai, Atsushi Yoshida, Keisuke Kohno, David Altshuler, Mio Nakamura, Kimberly A. Brown, Marwan S. Abouljoud, Dilip Moonka, Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation, Hepatology, 2014, 59, 1
  19. 19
    Fabio Gasparin, Renata Genaro Aguiar, Gabriela Lourençon Ioshimoto, Armando Silva-Cunha, Silvia Ligório Fialho, André Mauricio Liber, Balázs Vince Nagy, Nestor Norio Oiwa, Marcelo Fernandes Costa, Christina Joselevitch, Dora Fix Ventura, Francisco Max Damico, Pharmacokinetics, Electrophysiological, and Morphological Effects of the Intravitreal Injection of Mycophenolic Acid in Rabbits, Journal of Ocular Pharmacology and Therapeutics, 2014, 30, 6, 502

    CrossRef

  20. 20
    Mostafa K. El Awady, Noha G. Bader El Din, Mahmoud Abdel Aziz Riad, Moataza H. Omran, Tawfeek H. Abdelhafez, Tamer Mahmoud Elbaz, Shereen Shoukry Hunter, Reham M. Dawood, Ashraf O. Abdel Aziz, Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients, Disease Markers, 2014, 2014, 1

    CrossRef

  21. 21
    Deepak Joshi, Massimo Pinzani, Ivana Carey, Kosh Agarwal, Recurrent HCV after liver transplantation—mechanisms, assessment and therapy, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 12, 710

    CrossRef

  22. 22
    Jennifer A. Flemming, Parsia A. Vagefi, Chris E. Freise, Francis Y. Yao, Norah A. Terrault, Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: The hepatitis C experience, Liver Transplantation, 2014, 20, 10
  23. You have free access to this content23
    Z. M. Younossi, F. Kanwal, S. Saab, K. A. Brown, H. B. El-Serag, W. R. Kim, A. Ahmed, M. Kugelmas, S. C. Gordon, The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics, 2014, 39, 5
  24. You have free access to this content24
    JP Norvell, Josh Levitsky, Donor and recipient effects on graft and patient survival, Clinical Liver Disease, 2013, 2, 4
  25. 25
    A. García-Reyne, C. Lumbreras, I. Fernández, F. Colina, M. Abradelo, P. Magan, R. San-Juan, A. Manrique, F. López-Medrano, A. Fuertes, M. Lizasoain, E. Moreno, J.M. Aguado, Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation, Transplant Infectious Disease, 2013, 15, 4
  26. 26
    Carlos Jiménez-Romero, Marta Clemares-Lama, Alejandro Manrique-Municio, Alvaro García-Sesma, Jorge Calvo-Pulido, Enrique Moreno-González, Long-Term Results Using Old Liver Grafts for Transplantation: Sexagenerian Versus Liver Donors Older than 70 Years, World Journal of Surgery, 2013, 37, 9, 2211

    CrossRef

  27. You have free access to this content27
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  28. 28
    Jeffrey Campsen, Michael Zimmerman, James Trotter, Johnny Hong, Chris Freise, Robert S. Brown, Andrew Cameron, Mark Ghobrial, Igal Kam, Ronald Busuttil, Sammy Saab, Curtis Holt, Jean C. Emond, Jessica B. Stiles, Thresiamma Lukose, Matthew S. Chang, Göran Klintmalm, Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity, Clinical Transplantation, 2013, 27, 6
  29. 29
    Shih-Hsien Hsu, Ming-Lun Yeh, Shen-Nien Wang, New Insights in Recurrent HCV Infection after Liver Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  30. 30
    James Fung, See-Ching Chan, Cindy Cheung, Man-Fung Yuen, Kenneth Siu-Ho Chok, William Sharr, Albert Chi-Yan Chan, Tan-To Cheung, Wai-Kay Seto, Sheung-Tat Fan, Ching-Lung Lai, Chung-Mau Lo, Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B, The American Journal of Gastroenterology, 2013, 108, 6, 942

    CrossRef

  31. 31
    Jennifer C. Price, Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2013, 12, 4, 227

    CrossRef

  32. 32
    Tadahiro Uemura, Lucas E. Nikkel, Christopher S. Hollenbeak, Varun Ramprasad, Eric Schaefer, Zakiyah Kadry, How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?, Transplant International, 2012, 25, 6
  33. 33
    T. Uemura, V. Ramprasad, C. S. Hollenbeak, D. Bezinover, Z. Kadry, Liver Transplantation for Hepatitis C From Donation After Cardiac Death Donors: An Analysis of OPTN/UNOS Data, American Journal of Transplantation, 2012, 12, 4
  34. 34
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  35. 35
    Anbin Hu, Wenhua Liang, Zheng Zheng, Zhiyong Guo, Xiaoshun He, Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases, Journal of Hepatology, 2012, 57, 6, 1228

    CrossRef

  36. You have free access to this content36
    Norah A. Terrault, Michelle E. Roland, Thomas Schiano, Lorna Dove, Michael T. Wong, Fred Poordad, Margaret V. Ragni, Burc Barin, David Simon, Kim M. Olthoff, Lynt Johnson, Valentina Stosor, Dushyantha Jayaweera, John Fung, Kenneth E. Sherman, Aruna Subramanian, J. Michael Millis, Douglas Slakey, Carl L. Berg, Laurie Carlson, Linda Ferrell, Donald M. Stablein, Jonah Odim, Lawrence Fox, Peter G. Stock, Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection, Liver Transplantation, 2012, 18, 6
  37. You have free access to this content37
    Scott W. Biggins, Kiran M. Bambha, Norah A. Terrault, John Inadomi, Stephen Shiboski, Jennifer L. Dodge, Jane Gralla, Hugo R. Rosen, John P. Roberts, Projected future increase in aging hepatitis C virus–infected liver transplant candidates: A potential effect of hepatocellular carcinoma, Liver Transplantation, 2012, 18, 12
  38. 38
    Patricia Sheiner, Caroline Rochon, Recurrent Hepatitis C After Liver Transplantation, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2012, 79, 2
  39. 39
    Chuan Li, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Ming-Qing Xu, Wen-Tao Wang, Yong-Gang Wei, Safety of living donor liver transplantation using older donors, Journal of Surgical Research, 2012, 178, 2, 982

    CrossRef

  40. 40
    James J. Pomposelli, Elderly donors? 50 is the new 60, Liver Transplantation, 2011, 17, 5
  41. 41
    Rolland C. Dickson, Surakit Pungpapong, Andrew P. Keaveny, C. Burcin Taner, Marwan Ghabril, Jaime Aranda-Michel, Raj Satyanarayana, Hugo Bonatti, David J. Kramer, Justin H. Nguyen, Improving graft survival for patients undergoing liver transplantation, Clinical Transplantation, 2011, 25, 3
  42. 42
    Dae Y. Kim, Jang Moon, Eddie R. Island, Akin Tekin, Susan Ganz, David Levi, Gennaro Selvaggi, Seigo Nishida, Andreas G. Tzakis, Liver transplantation using elderly donors: a risk factor analysis, Clinical Transplantation, 2011, 25, 2
  43. 43
    Kayo Waki, Yasuhiko Sugawara, Sumihito Tamura, Makiko Naka Mieno, Noriyo Yamashiki, Takashi Kadowaki, Norihiro Kokudo, Outcome of Liver Transplantation for Recipients With Hepatitis B and Hepatitis C Virus Coinfection: Analysis of the UNOS Data, Transplantation, 2011, 92, 7, 809

    CrossRef

  44. 44
    Dennis Eurich, Marcus Bahra, Sabine Boas-Knoop, Johan F. Lock, Jennifer Golembus, Ruth Neuhaus, Peter Neuhaus, Ulf P. Neumann, Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus–-induced liver disease, Liver Transplantation, 2011, 17, 3
  45. 45
    Oswaldo Amaya, Juan Andrés Cuervo, Fernando Raffan, Fabián Manrique, Sergio Martínez, Trasplante hepático ortotópico en paciente con hemofilia A, Revista Colombiana de Anestesiología, 2011, 39, 1, 95

    CrossRef

  46. 46
    Richard S. Mangus, A. Joseph. Tector, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  47. 47
    Thomas A. Aloia, Richard Knight, A. Osama Gaber, R. Mark Ghobrial, John A. Goss, Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease–independent prognostic factors, Liver Transplantation, 2010, 16, 8
  48. 48
    Maurizio Biselli, Annagiulia Gramenzi, Massimo Del Gaudio, Matteo Ravaioli, Giovanni Vitale, Stefano Gitto, Gian Luca Grazi, Antonio Daniele Pinna, Pietro Andreone, Mauro Bernardi, Long Term Follow-up and Outcome of Liver Transplantation for Alcoholic Liver Disease, Journal of Clinical Gastroenterology, 2010, 44, 1, 52

    CrossRef

  49. 49
    Maria Trinidad Serrano, Agustín Garcia-Gil, Juan Arenas, Yolanda Ber, Luis Cortes, Carolina Valiente, Juan J. Araiz, Outcome of liver transplantation using donors older than 60 year of age, Clinical Transplantation, 2010, 24, 4
  50. 50
    Richard S. Mangus, Use of Hepatitis C–Infected Deceased Donors in Liver Transplantation, Current Hepatitis Reports, 2010, 9, 4, 253

    CrossRef

  51. 51
    W. Patkowski, K. Zieniewicz, M. Skalski, M. Krawczyk, Correlation Between Selected Prognostic Factors and Postoperative Course in Liver Transplant Recipients, Transplantation Proceedings, 2009, 41, 8, 3091

    CrossRef

  52. 52
    Daniel G. Maluf, Erick B. Edwards, R. Todd Stravitz, H. Myron Kauffman, Impact of the donor risk index on the outcome of hepatitis C virus–positive liver transplant recipients, Liver Transplantation, 2009, 15, 6
  53. 53
    Sandy Feng, Increased donor risk: Who should bear the burden?, Liver Transplantation, 2009, 15, 6
  54. 54
    Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, Alessandro Cucchetti, Giorgio Ercolani, Michelangelo Fiorentino, Ilaria Panzini, Marco Vivarelli, Giovanni Ramacciato, Massimo Del Gaudio, Gaetano Vetrone, Matteo Zanello, Alessandro Dazzi, Chiara Zanfi, Paolo Di Gioia, Valentina Bertuzzo, Augusto Lauro, Cristina Morelli, Antonio Daniele Pinna, Liver transplantations with donors aged 60 years and above: the low liver damage strategy, Transplant International, 2009, 22, 4
  55. 55
    Richard S. Mangus, Jonathan A. Fridell, Rodrigo M. Vianna, Paul Y. Kwo, Paul Chestovich, Martin L. Milgrom, Marwan Kazimi, Edward F. Hollinger, Jay Thomas Read, A. Joseph Tector, No difference in clinical transplant outcomes for local and imported liver allografts, Liver Transplantation, 2009, 15, 6
  56. 56
    Rosa M. Valadao, Norah A. Terrault, Older donors: Mounting risks for the hepatitis C–infected liver transplant recipient?, Liver Transplantation, 2009, 15, 7
  57. 57
    Jacqueline G. O'Leary, Henry Randall, Nicholas Onaca, Linda Jennings, Göran B. Klintmalm, Gary L. Davis, Post–liver transplant survival in hepatitis C patients is improving over time, Liver Transplantation, 2009, 15, 4
  58. 58
    Susanne Beckebaum, Georgios C. Sotiropoulos, Christian G. Klein, Christoph E. Broelsch, Fuat Saner, Andreas Paul, Guido Gerken, Vito R. Cicinnati, Predictive Factors of Outcome in Patients Transplanted for Hepatitis B, Transplantation, 2009, 87, 6, 872

    CrossRef

  59. 59
    Christopher D. Anderson, Neeta Vachharajani, Majella Doyle, Jeffrey A. Lowell, Jason R. Wellen, Surendra Shenoy, Mauricio Lisker-Melman, Kevin Korenblat, Jeff Crippin, William C. Chapman, Advanced Donor Age Alone Does Not Affect Patient or Graft Survival after Liver Transplantation, Journal of the American College of Surgeons, 2008, 207, 6, 847

    CrossRef

  60. 60
    John R. Lake, Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?, Liver Transplantation, 2008, 14, S2
  61. 61
    D. L. Segev, L. M. Kucirka, G. C. Nguyen, A. M. Cameron, J. E. Locke, C. E. Simpkins, P. J. Thuluvath, R. A. Montgomery, W. R. Maley, Effect Modification in Liver Allografts With Prolonged Cold Ischemic Time, American Journal of Transplantation, 2008, 8, 3
  62. 62
    C.G. Nudo, R.A. Cortes, D. Weppler, E.R. Schiff, A.G. Tzakis, A. Regev, Effect of Pretransplant Hepatitis C Virus RNA Status on Posttransplant Outcome, Transplantation Proceedings, 2008, 40, 5, 1449

    CrossRef

  63. 63
    I.F.S.F. Boin, E.C. Ataide, M.I. Leonardi, R. Stucchi, T. Sevá-Pereira, I.W. Pereira, A.R. Cardoso, C.A. Caruy, A. Luzo, L.S. Leonardi, Elderly Donors for HCV+ Versus Non-HCV Recipients: Patient Survival Following Liver Transplantation, Transplantation Proceedings, 2008, 40, 3, 792

    CrossRef

  64. 64
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  65. 65
    Matteo Cescon, Gian Luca Grazi, Alessandro Cucchetti, Matteo Ravaioli, Giorgio Ercolani, Marco Vivarelli, Antonietta D'Errico, Massimo Del Gaudio, Antonio Daniele Pinna, Improving the outcome of liver transplantation with very old donors with updated selection and management criteria, Liver Transplantation, 2008, 14, 5
  66. 66
    Adnan Said, Michael R Lucey, Liver transplantation: an update 2008, Current Opinion in Gastroenterology, 2008, 24, 3, 339

    CrossRef

  67. 67
    Poor Science Is Cited in “Older Donor” Study, American Journal of Transplantation, 2008, 8, 11
  68. 68
    Marina Berenguer, Risk of extended criteria donors in hepatitis C virus–positive recipients, Liver Transplantation, 2008, 14, S2
  69. 69
    Jeffrey J. Gaynor, Jang I. Moon, Tomoaki Kato, Seigo Nishida, Gennaro Selvaggi, David M. Levi, Eddie R. Island, Nikolaos Pyrsopoulos, Debbie Weppler, Susan Ganz, Phillip Ruiz, Andreas G. Tzakis, A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 877 Adults Who Received Primary Orthotopic Liver Transplantation, Transplantation, 2007, 84, 2, 155

    CrossRef

  70. 70
    Marcus Mottershead, James Neuberger, Grafts and hepatitis C virus: Maximizing the benefit, Liver Transplantation, 2007, 13, 7
  71. 71
    F. Draghi, A. Spinazzola, D. Abbati, M. Precerutti, C. Fachinetti, Hepatic sonography in the evaluation of potential multi-organ donors, Journal of Ultrasound, 2007, 10, 1, 1

    CrossRef

  72. 72
    Marcus Bahra, Dietmar Jacob, Ulf P. Neumann, Fabian Spies, Jan M. Langrehr, Thomas Berg, Ruth Neuhaus, Peter Neuhaus, Influence of Donor Histology on Outcome in Patients Undergoing Transplantation for Hepatitis C, Transplantation, 2007, 84, 2, 144

    CrossRef

  73. 73
    Adnan Said, Michael Einstein, Michael R Lucey, Liver transplantation: an update 2007, Current Opinion in Gastroenterology, 2007, 23, 3, 292

    CrossRef

  74. 74
    Jean F. Botha, Eric Thompson, Richard Gilroy, Wendy J. Grant, Sandeep Mukherjee, Elizabeth R. Lyden, Ira J Fox, Debra L. Sudan, Byers W. Shaw, Alan N. Langnas, Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation, Liver International, 2007, 27, 6
  75. 75
    Dorry L. Segev, Warren R. Maley, Christopher E. Simpkins, Jayme E. Locke, Geoffrey C. Nguyen, Robert A. Montgomery, Paul J. Thuluvath, Minimizing risk associated with elderly liver donors by matching to preferred recipients, Hepatology, 2007, 46, 6
  76. 76
    S.R. Johnson, S. Alexopoulos, M. Curry, D.W. Hanto, Primary Nonfunction (PNF) in the MELD Era: An SRTR Database Analysis, American Journal of Transplantation, 2007, 7, 4
  77. 77
    D. A. Axelrod, M. Schnitzler, P. R. Salvalaggio, J. Swindle, M. M. Abecassis, The Economic Impact of the Utilization of Liver Allografts with High Donor Risk Index, American Journal of Transplantation, 2007, 7, 4
  78. 78
    Paul J. Thuluvath, Karen L. Krok, Dorry L. Segev, Hwan Y. Yoo, Trends in post–liver transplant survival in patients with hepatitis C between 1991 and 2001 in the united states, Liver Transplantation, 2007, 13, 5
  79. 79
    S. Feng, M. Barr, J. Roberts, R. Oberbauer, B. Kaplan, Developments in Clinical Islet, Liver Thoracic, Kidney and Pancreas Transplantation in the Last 5 Years, American Journal of Transplantation, 2006, 6, 8
  80. 80
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  81. You have free access to this content81
    Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Liver transplantation for hepatitis C, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 5
  82. 82
    Adnan Said, Michael R Lucey, Liver transplantation: an update, Current Opinion in Gastroenterology, 2006, 22, 3, 272

    CrossRef

  83. 83
    A. Kuo, N. A. Terrault, Management of Hepatitis C in Liver Transplant Recipients, American Journal of Transplantation, 2006, 6, 3
  84. 84
    R. H. Wiesner, B. J. Steffen, K. M. David, A. H. Chu, R. D. Gordon, J. R. Lake, Mycophenolate Mofetil Use Is Associated with Decreased Risk of Late Acute Rejection in Adult Liver Transplant Recipients, American Journal of Transplantation, 2006, 6, 7
  85. 85
    Bruce Kaplan, Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome, Current Medical Research and Opinion, 2006, 22, 12, 2355

    CrossRef

  86. 86
    Teun van Gelder, Yann Le Meur, Leslie M. Shaw, Michael Oellerich, David DeNofrio, Curtis Holt, David W. Holt, Bruce Kaplan, Dirk Kuypers, Bruno Meiser, Burkhard Toenshoff, Richard D. Mamelok, Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation, Therapeutic Drug Monitoring, 2006, 28, 2, 145

    CrossRef

  87. 87
    Norah A. Terrault, Marina Berenguer, Treating hepatitis C infection in liver transplant recipients, Liver Transplantation, 2006, 12, 8
  88. 88
    A Joseph Tector, Richard S. Mangus, Paul Chestovich, Rodrigo Vianna, Jonathan A. Fridell, Martin L. Milgrom, Carrie Sanders, Paul Y. Kwo, Use of Extended Criteria Livers Decreases Wait Time for Liver Transplantation Without Adversely Impacting Posttransplant Survival, Transactions of the ... Meeting of the American Surgical Association, 2006, 124, 105

    CrossRef

  89. 89
    Sandy Feng, John Roberts, An Older Liver in the Hand, or a (Possibly) Younger Liver in the Bush?, American Journal of Transplantation, 2005, 5, 3
  90. 90
    Gero Puhl, Ulf Peter Neumann, How does donor age influence the success of liver transplantation in patients with hepatitis?, Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2, 8, 350

    CrossRef

  91. 91
    Russell H. Wiesner, Jolene S. Shorr, Bettina J. Steffen, Alice H. Chu, Robert D. Gordon, John R. Lake, Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C, Liver Transplantation, 2005, 11, 7
  92. 92
    Sandy Feng, Selecting livers for transplantation: can beggars be choosers?, Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2, 11, 496

    CrossRef

  93. 93
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,
  94. 94
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,